RxLabelGuard delivers FDA-sourced drug interaction data through a REST API with severity scoring, mechanism details, and evidence citations. Transparent pricing starting at $0/month. No enterprise procurement required.
Elsevier's Gold Standard Drug Database is a comprehensive drug information resource that powers the Clinical Pharmacology platform. It is one of several major drug data products in the healthcare information market, alongside First Databank, Micromedex, and Lexicomp. Elsevier, one of the world's largest scientific and medical publishers, acquired Gold Standard in 2012 to expand its clinical decision support offerings.
The Gold Standard Drug Database includes drug monographs, drug-drug interaction data, drug identification tools (pill identification by imprint, shape, and color), IV compatibility information, patient education materials, and clinical calculators. The Clinical Pharmacology platform built on this database is used by hospitals, health systems, retail pharmacies, and academic institutions.
The drug interaction module within Clinical Pharmacology provides severity classifications, mechanism descriptions, and management recommendations for drug-drug interactions. It also covers drug-food interactions, drug-ethanol interactions, and drug-lab test interactions. The interaction data is maintained by a team of clinical editors who review primary literature, FDA safety communications, and manufacturer labeling changes.
Elsevier also offers a Drug Interaction API as part of their clinical data solutions portfolio. This API allows healthcare software vendors to integrate Gold Standard interaction checking into their platforms. However, access requires an enterprise licensing agreement with Elsevier, and pricing is not publicly available. The sales process typically involves custom quotes based on deployment scope, transaction volume, and integration requirements.
For teams that need the full breadth of Clinical Pharmacology's reference content, the Gold Standard platform is a comprehensive option. But for teams that specifically need programmatic drug interaction checking through a modern REST API with transparent pricing and self-service onboarding, the enterprise licensing model may represent more friction than the use case requires.
Elsevier's Drug Interaction API and Clinical Pharmacology platform require enterprise licensing agreements with custom pricing. Startups, smaller development teams, and individual healthcare developers building focused applications often find that the minimum commitment exceeds their budget for a single use case like interaction checking.
The Gold Standard Drug Database encompasses drug monographs, pill identification, IV compatibility, patient education, and clinical calculators. When a team specifically needs drug interaction checking with severity scoring and evidence citations, licensing the full Clinical Pharmacology platform introduces cost and complexity for features that will not be used.
Enterprise data licensing with Elsevier involves sales consultations, contract negotiations, legal review, and integration planning. For development teams that want to send drug names to an API endpoint and receive structured interaction data back, this procurement overhead delays product delivery.
There is no public signup where developers can create an account, generate an API key, and start querying drug interactions immediately. The evaluation process requires engaging Elsevier's sales team, which can add weeks or months before a team can begin testing.
Development teams need pricing they can include in project budgets and financial projections. Publicly listed pricing tiers with clear request limits allow teams to plan their costs without waiting for a custom quote from a sales representative.
Healthcare applications increasingly need to demonstrate the provenance of clinical data. Teams need interaction results that include verifiable FDA label references -- SPL Set IDs, label sections, and evidence text -- for compliance documentation and clinical audit trails.
An honest side-by-side comparison to help you evaluate which solution fits your needs.
| Feature | Elsevier Gold Standard | RxLabelGuard |
|---|---|---|
| Data Source | Proprietary curated database with editorial review by clinical pharmacists | FDA Structured Product Labeling (public, verifiable) |
| Scope | Full clinical reference: drug monographs, interactions, pill ID, IV compatibility, patient education, calculators | Focused on drug interaction detection with severity scoring and evidence citations |
| Pricing | Enterprise licensing with custom quotes (contact sales, not publicly listed) | Free tier ($0), Developer ($20/mo), Professional ($99/mo) |
| Setup Time | Enterprise sales process: weeks to months (evaluation, contract, integration) | Self-service: minutes to first API call |
| Free Tier | No free tier available | Yes -- 50 requests/month on Sandbox plan |
| API Access | Drug Interaction API available through enterprise licensing agreement | Standard REST API with JSON responses, self-service signup |
| Interaction Types | Drug-drug, drug-food, drug-ethanol, drug-lab test interactions | Drug-drug interactions with severity scoring and evidence citations |
| Interaction Output | Severity classification, clinical significance, management recommendations | Severity, mechanism of action, clinical recommendations, evidence citations |
| Evidence Citations | References to clinical literature and pharmacological studies | SPL Set ID + FDA label section + evidence text snippet per interaction |
| Drug Resolution | Proprietary drug identifiers with NDC and other code mappings | RxNorm (RxCUI), NDC codes, brand and generic names with fuzzy matching |
| Self-Service Signup | No -- requires enterprise sales process and licensing agreement | Yes -- create account, generate API key, start testing immediately |
Elsevier Gold Standard offers broader clinical content including comprehensive drug monographs, pill identification, IV compatibility, patient education, and clinical calculators through Clinical Pharmacology. RxLabelGuard focuses specifically on drug interaction detection with FDA-sourced evidence citations and self-service API access.
Three steps from drug names to structured interaction data.
Pass drug names, NDC codes, or RxCUI identifiers to our REST API endpoint. We accept brand names, generic names, and common abbreviations.
Your input is normalized to RxCUI via RxNorm fuzzy matching, then we retrieve the latest FDA Structured Product Label for each drug.
Receive interaction pairs with severity level, mechanism of action, clinical recommendations, and FDA evidence citations including SPL Set ID and label section.
Check drug interactions in your language of choice. All responses include severity scoring and FDA evidence citations.
curl -X POST https://jd6095ijga.execute-api.us-east-2.amazonaws.com/v1/interactions/check \
-H "Content-Type: application/json" \
-H "x-api-key: YOUR_API_KEY" \
-d '{
"drugs": ["fluoxetine", "tramadol"]
}'import requests
response = requests.post(
"https://jd6095ijga.execute-api.us-east-2.amazonaws.com/v1/interactions/check",
headers={
"Content-Type": "application/json",
"x-api-key": "YOUR_API_KEY",
},
json={"drugs": ["fluoxetine", "tramadol"]},
)
data = response.json()
for interaction in data.get("interactions", []):
print(f"{interaction['severity']}: {interaction['description']}")const response = await fetch(
"https://jd6095ijga.execute-api.us-east-2.amazonaws.com/v1/interactions/check",
{
method: "POST",
headers: {
"Content-Type": "application/json",
"x-api-key": "YOUR_API_KEY",
},
body: JSON.stringify({ drugs: ["fluoxetine", "tramadol"] }),
}
);
const data = await response.json();
data.interactions.forEach((interaction) => {
console.log(`${interaction.severity}: ${interaction.description}`);
});Teams move from enterprise drug data platforms to focused APIs when their specific use case does not require the full breadth of Clinical Pharmacology.
Development teams building drug interaction checking into electronic health record systems need an API they can call at the point of prescribing. A self-service API with clear documentation reduces integration time from months to days.
Pharmacy software vendors and PBMs embedding interaction alerts into dispensing or claims adjudication workflows need programmatic access to interaction data. Pay-per-use pricing aligns cost with actual transaction volume.
Digital health startups and telehealth platforms need lightweight drug interaction checking that fits within their existing API architecture. A free tier allows prototyping before committing to a paid plan.
Teams building specialized clinical decision support tools need interaction data they can incorporate into their own scoring and alerting logic, not a bundled reference platform with a fixed UI and broader feature set.
Start free. Scale as you grow. No enterprise sales cycle required.
50 requests/month, 1 API key
2,000 requests/month, 5 API keys
20,000 requests/month, unlimited keys
Common questions about switching from Elsevier Gold Standard to an API-based drug interaction solution.
No. Elsevier's Gold Standard Drug Database powers the Clinical Pharmacology platform, which includes comprehensive drug monographs, pill identification tools, IV compatibility data, patient education materials, and clinical calculators. RxLabelGuard is a focused drug interaction detection API.
If your use case is specifically drug interaction checking via a programmatic API -- for example, embedding interaction alerts into an EHR module, pharmacy tool, or telehealth application -- RxLabelGuard is a suitable alternative. If you need the full Clinical Pharmacology reference suite, Gold Standard serves a broader purpose.
Yes. Elsevier offers a Drug Interaction API as part of their clinical data solutions portfolio, built on the Gold Standard Drug Database. This API allows healthcare software vendors to integrate interaction checking into their platforms.
However, access requires an enterprise licensing agreement with Elsevier, and pricing is not publicly available. There is no self-service signup, free tier, or public developer documentation. RxLabelGuard offers self-service API access with a free Sandbox tier (50 requests/month), publicly listed pricing, and documentation you can review before signing up.
FDA Structured Product Labeling (SPL) is the authoritative source of drug interaction information for FDA-approved medications. Every approved drug must include interaction information in its label. This data is public, independently verifiable, and updated as the FDA processes label revisions.
Gold Standard's curated database adds significant value: editorial review by clinical pharmacists, additional interaction types (drug-food, drug-ethanol, drug-lab test), and detailed clinical monographs. However, this curation is proprietary, meaning you cannot independently verify the editorial decisions.
The practical difference depends on your use case. If you need traceable, auditable drug-drug interaction data from an authoritative public source, RxLabelGuard provides that. If you need the broadest possible interaction coverage including non-drug-drug interactions, Gold Standard offers that at enterprise pricing.
Currently, RxLabelGuard focuses specifically on drug-drug interactions with severity scoring and evidence citations. This covers the most common clinical use case for drug interaction checking in healthcare software.
Elsevier Gold Standard also covers drug-food interactions, drug-ethanol interactions, and drug-lab test interactions. If these additional interaction types are critical to your application, Gold Standard may be a better fit for that specific requirement. For drug-drug interaction checking specifically, RxLabelGuard provides equivalent functionality with self-service access and transparent pricing.
Yes. RxLabelGuard accepts drug names (brand or generic), NDC codes, and RxCUI identifiers, making it straightforward to adapt existing integrations. The response format is structured JSON with severity, mechanism, recommendation, and evidence fields.
The key difference to be aware of: RxLabelGuard sources data from FDA Structured Product Labeling rather than Gold Standard's proprietary curated database. Coverage may differ in some cases, particularly for non-drug-drug interactions. We recommend testing your critical drug pairs with our free Sandbox tier (50 requests/month) to validate coverage for your specific use case before fully migrating.
Create a free account and test with your critical drug pairs. No credit card, no sales call, no enterprise licensing process. Go from sign-up to first API response in minutes.
Already evaluating? Learn more about the free tier
Medical Disclaimer: This information is derived from FDA Structured Product Labeling and is provided for informational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Gold Standard, Clinical Pharmacology, and Elsevier are trademarks of Elsevier B.V. or its affiliates. RxLabelGuard is not affiliated with or endorsed by Elsevier.